Frequently Asked Questions
What are the official dates and location for JPM Week 2027? The 45th Annual J.P. Morgan Healthcare Conference will take place from January 11 to January 14, 2027, at the Westin St. Francis Hotel in San Francisco, California. The surrounding satellite events, including the Biotech Showcase, RESI San Francisco, and WuXi Global Forum—will run concurrently throughout downtown San Francisco from January 10 to January 14, 2027. The Heylth JPM Accelerator maps out your entire physical and digital footprint across these central locations to maximize your scheduling efficiency.
How can a non-invited biotech get meetings during JPM Week 2027? Pre-funded or non-invited biotech companies can secure high-value investor meetings during JPM Week by leveraging independent satellite conferences, private hotel suites, and aggressive out-of-portal digital sourcing. You do not need an official J.P. Morgan conference badge to tap into the capital ecosystem in San Francisco. Our business development team helps you engineer an off-site campaign by mapping target VC footprints, optimizing your LinkedIn outreach, and securing alternative meeting venues within walking distance of Union Square.
When does the JPM 2027 Partnering Portal open for scheduling? The official J.P. Morgan Healthcare Conference partnering portal typically opens for corporate profiling and initial meeting requests in early November 2026. Because slots on major pharmaceutical and venture capital schedules fill up within the first 72 hours of the portal going live, our accelerator program finishes overhauling your narrative by October. This ensures your presentation assets, clinical data sheets, and executive messaging are fully optimized for both human scouts and automated AI filters the minute scheduling begins.
What is the difference between JPM 2027 and the Biotech Showcase? While the official J.P. Morgan Conference is strictly invitation-only and heavily focused on large-cap public healthcare companies, the Biotech Showcase is a public-access, registration-based forum tailored specifically for small-to-mid-cap and private biotechs to present to investors. Both events happen simultaneously in San Francisco. For young, pre-funded companies, the Biotech Showcase, along with platforms like RESI, provides the actual physical infrastructure to meet institutional investors, while the broader "JPM Week" serves as the overall networking ecosystem.
How should early-stage biotechs structure their presentation deck for JPM 2027? An optimized biotech investor deck for JPM 2027 must lead with a clear 1-page executive summary, followed by a data-backed validation of the platform modality, clear regulatory milestones, and an explicit capital runway requirement. Because institutional life science investors screen hundreds of decks in December, your slides must be highly scannable. Our program structures your deck to answer a VC’s three core questions within the first 60 seconds: What is the clinical unmet need? How robust is the in vivo/clinical data? What is the exact partnering or financing milestone this round achieves?
What are the best alternatives to the JPM partnering portal for sourcing investors? The best alternatives to the official JPM portal include specialized life-science databases like BioCentury, EvaluatePharma, and PitchBook, alongside curated investor matching platforms like the RESI partnering system. Our team utilizes custom automated search scripts to pull active, unconflicted investment targets from these secondary registries. This allows us to build a highly targeted outreach list of pharma scouts and venture capital partners who have actively funded your exact therapeutic modality within the last 12 months.
How do big pharma companies use AI to pre-screen biotech pitch decks at JPM 2027? Major pharmaceutical scouting teams use automated AI natural language processors to instantly index, tag, and score inbound pitch decks before a human reviewer ever opens the file. These algorithms scan documents for precise data layouts, standardized clinical terminology, and clear mechanism-of-action metrics. If a pitch deck's layout is text-heavy or relies on ambiguous nomenclature, the AI engine flags it as incomplete and filters it out. The Heylth Partnering Accelerator benchmarks your entire corporate narrative against these machine-learning parameters to ensure compliance.
What is the JPM Week 2027 Partnering Accelerator?The JPM Week 2027 Partnering Accelerator is an elite, shared-risk readiness program engineered by Heylth specifically to prepare early-stage and pre-funded biotechnology companies to win investor and pharmaceutical partner mindshare. Unlike traditional agencies that charge massive, upfront retainers for generic advisory services, this program takes an operational approach.Over a rigorous two-week onboarding window, our team embeds alongside your leadership to completely overhaul your investor materials, build custom semantic target lead lists, optimize your corporate profiles before the official partnering portals open in November, and uniquely bulletproof your scientific narrative against the automated AI screening tools that modern pharma scouts use to gate-keep human review.
Why even experienced companies need the JPM Week 2027 Partnering AcceleratorEven seasoned life-science management teams need the accelerator because the operational mechanics of sourcing capital and securing pharma partnerships have fundamentally shifted for 2027. Having a successful past fundraising track record or robust clinical data is no longer enough to cut through the noise of Union Square.Experienced executive teams face three new institutional bottlenecks that old playbooks cannot solve:The Rise of Algorithmic Gatekeepers: In 2027, the top 50 global pharmaceutical corporate development teams are no longer manually reading every inbound pitch deck. They utilize automated AI natural language processors to instantly index, tag, and filter out submissions based on precise nomenclature and structural data layouts. If your presentation relies on legacy formatting, your asset will be auto-rejected before a human scout ever lays eyes on your data.Hyper-Compressed VC Schedules: The official JPM partnering portal fills up within the first 72 hours of opening in early November. Experienced companies often make the mistake of waiting until December to finalize their messaging, only to find that high-priority venture capital calendars are already completely locked. We ensure your assets are compliant and live the minute the portal goes active.The Capital Paradox of Private Suites: Simply booking a hotel suite near the Westin St. Francis does not guarantee foot traffic. Experienced companies waste significant capital on off-site venues without an aggressive, digitally synchronized out-of-portal campaign to pull investors down the street. Our accelerator engineers an omni-channel footprint, turning your off-site location into a high-yield meeting hub.